SCHEMBL4585539

SCHEMBL4585539

CCCCCCCCCCC(C)OCCOCCOCCO

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
THRB P10828 1/20 0.60
HTT P42858 1/20 0.60
MAPT P10636 1/20 0.60
TSHR P16473 2/20 0.50
LMNA P02545 4/20 0.42
USP2 O75604 2/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 1/20 0.42
MAPK1 P28482 1/20 0.42
CASP1 P29466 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SLCO1B3 Q9NPD5 1/20 0.42
SLCO1B1 Q9Y6L6 1/20 0.42
FAAH O00519 5/20 0.38
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
HSD17B10 Q99714 1/20 0.37
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29592570 1.00 MEN1 (0.60) MEN1KMT2ATHRBHTTMAPT
SCHEMBL31601988 1.00 MEN1 (0.60) MEN1KMT2ATHRBHTTMAPT
SCHEMBL4750679 1.00 MEN1 (0.60) MEN1KMT2ATHRBHTTMAPT
SCHEMBL14169158 1.00 MEN1 (0.60) MEN1KMT2ATHRBHTTMAPT
SCHEMBL11060042 1.00 MEN1 (0.60) MEN1KMT2ATHRBHTTMAPT
SCHEMBL5316151 1.00 MEN1 (0.60) MEN1KMT2ATHRBHTTMAPT
SCHEMBL11659395 1.00 MEN1 (0.60) MEN1KMT2ATHRBHTTMAPT
SCHEMBL5316580 1.00 MEN1 (0.60) MEN1KMT2ATHRBHTTMAPT
SCHEMBL4592663 1.00 MEN1 (0.60) MEN1KMT2ATHRBHTTMAPT
SCHEMBL28755230 1.00 MEN1 (0.60) MEN1KMT2ATHRBHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12508218-B2 Coating compositions COTY INC. (US) 2025-12-30 US disclosed
US-20250152487-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF COTY INC. 2025-05-15 US disclosed
US-20250127694-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF COTY INC. 2025-04-24 US disclosed
US-20250127707-A1 FRAGRANCE FORMULATION COTY INC. 2025-04-24 US disclosed
US-20250032371-A1 ETHANOL-FREE FRAGRANCE CHASSIS COTY INC. 2025-01-30 US disclosed
US-12178896-B2 Fragrance compositions and uses thereof COTY INC. (US) 2024-12-31 US disclosed
US-20230285261-A1 FRAGRANCE COMPOSITION COMPRISING A FRAGRANCE COMPONET AND A NON-ODOROUS FRAGRANCE MODULATOR JPMORGAN CHASE BANK, N.A. 2023-09-14 US disclosed
EP-3141239-B1 FRAGRANCE COMPOSITIONS AND USES THEREOF PROCTER & GAMBLE (US) 2023-05-10 EP disclosed
US-20220304914-A1 COATING COMPOSITIONS JPMORGAN CHASE BANK, N.A. 2022-09-29 US disclosed
EP-1546085-A4 LIPOPHILIC DIESTERS OF CHELATING AGENT FOR INHIBITION OF ENZYME ACTIVITY DPHARM LTD (IL) 2008-03-26 EP disclosed
EP-1546085-A2 LIPOPHILIC DIESTERS OF CHELATING AGENT FOR INHIBITION OF ENZYME ACTIVITY D-Pharm Ltd. (IL) 2005-06-29 EP disclosed
WO-2004028443-A2 LIPOPHILIC DIESTERS OF CHELATING AGENT FOR INHIBITION OF ENZYME ACTIVITY D-PHARM LTD. (IL) 2004-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220304914-A1 COATING COMPOSITIONS OR10J3, OR51E2, TAS2R20 MEN1 3869/4885KMT2A 1455/4885THRB 3352/4885
US-12178896-B2 Fragrance compositions and uses thereof FHIT, ALG3, FEM1B MEN1 2579/4885KMT2A 1368/4885THRB 3384/4885
US-20250032371-A1 ETHANOL-FREE FRAGRANCE CHASSIS OR51E2, FDFT1, ELANE MEN1 1265/4885KMT2A 3610/4885THRB 3739/4885
US-20250127694-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF TRPA1, TRPV1, NAA40 MEN1 1906/4885KMT2A 1443/4885THRB 4562/4885
US-20250127707-A1 FRAGRANCE FORMULATION PUF60, POLM, ADH5 MEN1 3678/4885KMT2A 1411/4885THRB 3530/4885
US-20230285261-A1 FRAGRANCE COMPOSITION COMPRISING A FRAGRANCE COMPONET AND A NON-ODOROUS FRAGRANCE MODULATOR OR51E2, TRPA1, FAM120A MEN1 3300/4885KMT2A 886/4885THRB 3729/4885
US-12508218-B2 Coating compositions TAS2R40, TAS2R20, TAS2R10 MEN1 4739/4885KMT2A 3220/4885THRB 3077/4885
US-20250152487-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF FHIT, ALG3, FEM1B MEN1 2579/4885KMT2A 1368/4885THRB 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.